» Articles » PMID: 21406293

Molecular Regulation of Phosphate Metabolism by Fibroblast Growth Factor-23-klotho System

Overview
Specialty Nephrology
Date 2011 Mar 17
PMID 21406293
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Phosphorus is an essential nutrient and is routinely assimilated through consumption of food. The body's need of phosphate is usually fulfilled by intestinal absorption of this element from the consumed food, whereas its serum level is tightly regulated by renal excretion or reabsorption. Sodium-dependent phosphate transporters, located in the luminal side of the proximal tubular epithelial cells, have a molecular control on renal phosphate excretion and reabsorption. The systemic regulation of phosphate metabolism is a complex multiorgan process, and the identification of fibroblast growth factor-23 (FGF23)-Klotho system as a potent phosphatonin has provided new mechanistic insights into the homeostatic control of phosphate. Hypophosphatemia as a result of an increase in urinary phosphate wasting after activation of the FGF23-Klotho system is a common phenomenon, observed in both animal and human studies, whereas suppression of the FGF23-Klotho system leads to the development of hyperphosphatemia. This article will briefly summarize how delicate interactions of the FGF23-klotho system can regulate systemic phosphate homeostasis.

Citing Articles

Tasurgratinib in patients with cholangiocarcinoma or gastric cancer: Expansion part of the first-in-human phase I study.

Morizane C, Ueno M, Ioka T, Tajika M, Ikeda M, Yamaguchi K Cancer Sci. 2024; 116(1):192-203.

PMID: 39462221 PMC: 11711049. DOI: 10.1111/cas.16354.


Sugar sweetened beverage consumption is positively associated with Klotho levels at two years of age in LatinX youth.

Villagomez S, Dubal D, Hawkins J, Wang D, Wojcicki J BMC Nutr. 2021; 7(1):22.

PMID: 33888157 PMC: 8063295. DOI: 10.1186/s40795-021-00423-5.


FGF/FGFR Signaling in Hepatocellular Carcinoma: From Carcinogenesis to Recent Therapeutic Intervention.

Wang Y, Liu D, Zhang T, Xia L Cancers (Basel). 2021; 13(6).

PMID: 33802841 PMC: 8002748. DOI: 10.3390/cancers13061360.


Associated factors related to chronic kidney disease progression in elderly patients.

Totoli C, Carvalho A, Ammirati A, Draibe S, Canziani M PLoS One. 2019; 14(7):e0219956.

PMID: 31335919 PMC: 6650050. DOI: 10.1371/journal.pone.0219956.


Derazantinib (ARQ 087) in advanced or inoperable FGFR2 gene fusion-positive intrahepatic cholangiocarcinoma.

Mazzaferro V, El-Rayes B, Droz Dit Busset M, Cotsoglou C, Harris W, Damjanov N Br J Cancer. 2018; 120(2):165-171.

PMID: 30420614 PMC: 6342954. DOI: 10.1038/s41416-018-0334-0.


References
1.
Razzaque M, Lanske B . The emerging role of the fibroblast growth factor-23-klotho axis in renal regulation of phosphate homeostasis. J Endocrinol. 2007; 194(1):1-10. PMC: 2900827. DOI: 10.1677/JOE-07-0095. View

2.
Razzaque M . The dualistic role of vitamin D in vascular calcifications. Kidney Int. 2010; 79(7):708-14. PMC: 3120050. DOI: 10.1038/ki.2010.432. View

3.
Razzaque M . Phosphate toxicity: new insights into an old problem. Clin Sci (Lond). 2010; 120(3):91-7. PMC: 3120105. DOI: 10.1042/CS20100377. View

4.
Ben-Dov I, Galitzer H, Lavi-Moshayoff V, Goetz R, Kuro-O M, Mohammadi M . The parathyroid is a target organ for FGF23 in rats. J Clin Invest. 2007; 117(12):4003-8. PMC: 2066196. DOI: 10.1172/JCI32409. View

5.
Gutierrez O, Mannstadt M, Isakova T, Rauh-Hain J, Tamez H, Shah A . Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis. N Engl J Med. 2008; 359(6):584-92. PMC: 2890264. DOI: 10.1056/NEJMoa0706130. View